NCT04887766View on ClinicalTrials.gov

Study on GS300 on NAFLD

NAUnknownINTERVENTIONAL

Enrollment

250

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions

Nonalcoholic Fatty LiverWeight Loss

Interventions

DEVICE

GS300

Gelesis300 hydrogel in gelatin capsules

DEVICE

Placebo

Placebo capsules

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Gelesis, Inc.

INDUSTRY

NCT04887766 - Study on GS300 on NAFLD | Biotech Hunter | Biotech Hunter